Latest Articles
Oxytocin’s new role in delaying embryo development revealed - MSN
Oxytocin’s new role in delaying embryo development revealed MSN
Published: March 6, 2025, 3:18 a.m.
The impact of intrauterine adhesions on endometrial receptivity in patients undergoing in vitro fertilization-embryo transfer - Frontiers
The impact of intrauterine adhesions on endometrial receptivity in patients undergoing in vitro fertilization-embryo transfer Frontiers
Published: March 5, 2025, 9:36 p.m.
Dr Wagar on Lenvatinib Plus Pembrolizumab vs Chemo in First-Line Advanced Endometrial Cancer - OncLive
Dr Wagar on Lenvatinib Plus Pembrolizumab vs Chemo in First-Line Advanced Endometrial Cancer OncLive
Published: March 5, 2025, 8:17 p.m.
Environmental and Health Groups Welcome “Toxic” Designation of Forever Chemicals - Environmental Defence
Environmental and Health Groups Welcome “Toxic” Designation of Forever Chemicals Environmental Defence
Published: March 5, 2025, 7:06 p.m.
Women claim they were needlessly sterilized by East Memphis doctor facing federal charges - MSN
Women claim they were needlessly sterilized by East Memphis doctor facing federal charges MSN
Published: March 5, 2025, 4:22 p.m.
“When you try explain it to them, they don’t really understand” – Endometriosis Awareness Week 2025 - Salford Now
“When you try explain it to them, they don’t really understand” – Endometriosis Awareness Week 2025 Salford Now
Published: March 5, 2025, 4 p.m.
Emmerdale star opens up about her life in region and 'debilitating' condition - The Northern Echo
Emmerdale star opens up about her life in region and 'debilitating' condition The Northern Echo
Published: March 5, 2025, 4 p.m.
Synthetic Braiding Hair Contains Cancer-Causing Chemicals: Consumer Reports - AboutLawsuits.com
Synthetic Braiding Hair Contains Cancer-Causing Chemicals: Consumer Reports AboutLawsuits.com
Published: March 5, 2025, 4 p.m.
Fell Brewery beer will aid endemetriosis charity - - Beer Today
Fell Brewery beer will aid endemetriosis charity - Beer Today
Published: March 5, 2025, 12:17 p.m.
Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial - Nature.com
Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial Nature.com
Published: March 5, 2025, 11:04 a.m.
Link copied to clipboard!